CORVEL CORP — Director's Dealing 2024

Feb 10, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CORVEL CORP (CRVL)
CIK: 0000874866
Period of Report: 2024-02-07

Reporting Person: HAMERSLAG STEVEN J (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-02-07	Common Stock	M	1000	$48.35	Acquired	1000	Direct
2024-02-07	Common Stock	M	3000	$57.35	Acquired	4000	Direct
2024-02-07	Common Stock	M	3000	$87.49	Acquired	7000	Direct
2024-02-07	Common Stock	F	2079	$232.26	Disposed	4921	Direct
2024-02-07	Common Stock	G	4921	$0.00	Disposed	0	Direct
2024-02-07	Common Stock	G	4921	$0.00	Acquired	116389	Indirect
2024-02-08	Common Stock	S	1192	$239.67	Disposed	115197	Indirect
2024-02-08	Common Stock	S	808	$240.36	Disposed	114389	Indirect
2024-02-09	Common Stock	S	927	$238.21	Disposed	113462	Indirect
2024-02-09	Common Stock	S	1019	$239.52	Disposed	112443	Indirect
2024-02-09	Common Stock	S	255	$240.27	Disposed	112188	Indirect
2024-02-09	Common Stock	S	430	$241.42	Disposed	111758	Indirect
2024-02-09	Common Stock	S	290	$242.32	Disposed	111468	Indirect

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2024-02-07	Non-Qualified Stock Option (Right to Buy)	$48.35	M	1000	Disposed	2027-08-03	Common Stock (1000)	Direct
2024-02-07	Non-Qualified Stock Option (Right to Buy)	$57.35	M	3000	Disposed	2028-08-02	Common Stock (3000)	Direct
2024-02-07	Non-Qualified Stock Option (Right to Buy)	$87.49	M	3000	Disposed	2029-08-08	Common Stock (3000)	Direct

Footnotes

F1: Reflects the exercise of stock options awarded to the Reporting Person on August 3, 2017. The options became exercisable in four equal and successive annual installments commencing 12 months following the grant date.

F2: Reflects the exercise of stock options awarded to the Reporting Person on August 2, 2018. The options became exercisable in four equal and successive annual installments commencing 12 months following the grant date.

F3: Reflects the exercise of stock options awarded to the Reporting Person on August 8, 2019. The options became exercisable in four equal and successive annual installments commencing 12 months following the grant date.

F4: Reflects shares of the Issuer's common stock, par value $0.0001 per share ("Common Stock"), withheld by the Issuer to cover the Reporting Person's exercise price of the stock options reported herein.

F5: On February 7, 2024, the Reporting Person made a bona fide gift of 4,921 shares of Common Stock to the Steven J. Hamerslag and Jean Wells Hamerslag Trust Dtd. 12/09/88 (the "Hamerslag Trust"), of which the Reporting Person is a trustee.

F6: The shares of Common Stock are held indirectly by the Reporting Person as trustee of the Hamerslag Trust.

F7: Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $239.39 to $239.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission (the "Staff"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F8: Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $240.01 to $240.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F9: Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $238.00 to $238.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F10: Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $239.01 to $239.93, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F11: Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $240.01 to $240.79, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F12: Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $241.03 to $241.97, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F13: Reflects the weighted average price per share at which the shares of Common Stock were sold. The shares were sold in multiple transactions at prices ranging from $242.05 to $242.73, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the Staff, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.